Rebecca Brachman: A new class of drug that could prevent depression and PTSD
Rebecca Brachman: Un nou tipus de droga que podria prevenir la depressió i el TEPT
Rebecca Brachman is a pioneer in the field of preventative psychopharmacology, developing drugs to enhance stress resilience and prevent mental illness. Full bio
Double-click the English transcript below to play the video.
were made from, of all things,
de totes les possibles opcions,
després de la Segona Guerra Mundial.
avui en dia, un de cada cinc soldats
one in five soldiers develop depression,
o les dues coses.
són els únics que tenen
that are at high risk for these diseases.
els pacients de càncer,
cancer patients, aid workers, refugees --
els refugiats-
or major life stress.
a traumes o estrès vital important.
these disorders are,
malalties ben comunes,
if they work at all,
a la nostra disposició, si funcionen,
discovered the first vaccine --
va descobrir la primera vacuna --
a prophylactic for a disease,
un profilàctic per una malaltia,
podia prevenir la malaltia.
to extend to psychiatric diseases.
s’estenia a les malalties psiquiàtriques.
accidentally discovered
vam descobrir per casualitat
depression and PTSD.
prevenir depressió i TEPT.
whether they work in humans.
si funcionen en humans.
psychopharmaceuticals
la resiliència a l'estrès,
stress resilience,
potenciadors de la resiliència.
that you've since recovered from.
en el passat que ja hagueu superat.
you missed a flight.
o un examen, vas perdre un vol..
is the active biological process
el procés biològic actiu
to bounce back after stress.
després de l'estrès.
and your immune system fights it off.
i el sistema immunitari l'expulsa.
enough stressor,
psiquiàtrica, com la depressió.
such as depression.
malalties depressives importants
of major depressive disorder
amb els ratolins,
poden protegir-nos
against purely biological stressors,
purament biològics,
like bullying and isolation.
l'estrès com el bullying i l'aïllament.
en el que vam donar als ratolins
of stress hormones.
d'hormones de l'estrès.
without a psychological component.
d'estrès sense un component psicològic.
of antidepressant treatment beforehand,
de tractament antidepressiu per avançat,
enhancer given a week before
una dòsis individual
resiliència una setmana abans
the depressive behavior.
tres setmanes d'estrès.
a drug has ever been shown
que s'ha demostrat que una droga
often lifelong, clinical diseases.
per tota la vida.
of substance abuse, homelessness,
d'abús de substàncies, estar sense llar,
is over three trillion dollars per year.
de més de tres bilions de dolars a l'any.
where we know someone is predictively
que té un valor predictiu d'alt risc
to extreme stress.
going into an earthquake zone.
afectada per un terratrèmol.
contra la febre tifoide,
of a resilience enhancer
o una injecció
pistola els saquejadors o encara pitjor,
by looters or worse,
against developing depression or PTSD
contra depressió o TEPT
from experiencing the stress,
her susceptibility to depression and PTSD,
susceptibilitat a patir depressió i TEPT,
her home, her family or even her life.
de perdre la feina,
o fins i tot la pròpia vida.
the smallpox vaccine,
la vacuna contra la verola,
moltes altres vacunes.
al cap de 150 anys
was widely available.
va estar àmpliament disponible.
sensitive and creative and empathetic.
la gent sensible,
by constitution and not biology.
no a la biologia.
today about depression.
coses similars de la depressió.
opened the door
de Jenner va obrir la porta
that followed after,
que van arribar després,
la possibilitat d'un camp totalment nou:
open the possibility of a whole new field:
choose to do with it.
decidim fer amb això.
ABOUT THE SPEAKER
Rebecca Brachman - Neuroscientist, writer, entrepreneurRebecca Brachman is a pioneer in the field of preventative psychopharmacology, developing drugs to enhance stress resilience and prevent mental illness.
Why you should listen
Current treatments for mood disorders only suppress symptoms without addressing the underlying disease, and there are no known cures. The drugs Rebecca Brachman is developing would be the first to prevent psychiatric disorders such as post-traumatic stress disorder (PTSD) and depression.
Brachman completed her PhD at Columbia University, prior to which she was a fellow at the National Institutes of Health, where she discovered that immune cells carry a memory of psychological stress and that white blood cells can act as antidepressants and resilience-enhancers. Brachman's research has been featured in The Atlantic, WIRED and Business Insider, and her work was recently described by Dr. George Slavich on NPR as a "moonshot project that is very much needed in the mental health arena."
In addition to conducting ongoing research at Columbia, Brachman is an NYCEDC Entrepreneurship Lab Fellow and cofounder of Paravax -- a biotech startup developing vaccine-like prophylactic drugs ("paravaccines") -- along with her scientific collaborator, Christine Ann Denny. She is also working on a non-profit venture to repurpose existing generic drugs for use as prophylactics, and previously served as the Interim Program Director for Outreach at the Zuckerman Institute at Columbia University.
Brachman is also a playwright and screenwriter. She holds Bachelor's degrees in both neuroscience and creative wWriting, and she is currently working on a tech-focused writing project with her long-time writing partner, Sean Calder ("Grimm," "Damages," "ER"). She served as the director of NeuWrite, a national network of science-writing groups that fosters ongoing collaboration between scientists, writers and artists, and she has been featured as a storyteller at The Story Collider.
(Photo: Kenneth Willardt)
Rebecca Brachman | Speaker | TED.com